Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Ascendis Pharma A/S as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 203
- +15 vs. Q1 2024
- Shares held
- 60.7M
- −109.9K (−0.2%) vs. Q1 2024
- Total value
- $8.28B
- −$913.6M (−9.9%) vs. Q1 2024
- New holders
- 38
- 75 more added
- Sold out
- 23
- 67 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 313 | $17.8B |
| Q1 2026 | 274 | $14.3B |
| Q4 2025 | 303 | $13.8B |
| Q3 2025 | 281 | $12.7B |
| Q2 2025 | 248 | $10.9B |
| Q1 2025 | 245 | $10.1B |
| Q4 2024 | 215 | $8.78B |
| Q3 2024 | 220 | $9.31B |
| Q2 2024 | 203 | $8.28B |
| Q1 2024 | 189 | $9.19B |
| Q4 2023 | 185 | $7.59B |
| Q3 2023 | 160 | $5.64B |
| Q2 2023 | 158 | $5.45B |
| Q1 2023 | 164 | $6.54B |
| Q4 2022 | 187 | $8.05B |
| Q3 2022 | 183 | $6.89B |
| Q2 2022 | 168 | $5.88B |
| Q1 2022 | 177 | $7.27B |
| Q4 2021 | 172 | $7.85B |
| Q3 2021 | 166 | $9.24B |
| Q2 2021 | 171 | $7.24B |
| Q1 2021 | 177 | $6.83B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Ascendis Pharma A/S; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,922,555 | $671.3M | 0.04% | −15,906−0.3% | Reduced |
| Westfield Capital Management Co LP | 4,962,824 | $676.8M | 3.33% | +887,610+21.8% | Added |
| Ra Capital Management, L.P. | 10,108,400 | $1.38B | 18.23% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −109,000−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −48,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −33,661−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −24,151−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −19,412−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −12,754−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −6,564−100.0% | Sold out |
| AXS Investments LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,649−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,875−100.0% | Sold out |
| Pinpoint Asset Management Ltd | 0 | $0 | 0.00% | −1,698−100.0% | Sold out |
| CM Wealth Advisors LLC | 0 | $0 | 0.00% | −1,674−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −1,479−100.0% | Sold out |
| Icapital Wealth LLC | 0 | $0 | 0.00% | −1,451−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −1,448−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −1,406−100.0% | Sold out |
| Private Ocean, LLC | 0 | $0 | 0.00% | −241−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |